Landscape Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Landscape Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-22,200	Closed	-$577K	–	807
2015 Q1	$577K	Buy	22,200 +9,800	+79%	+$180K	0.15%	171
2014 Q4	$160K	Buy	+12,400	New	+$155K	0.08%	452

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Landscape Capital Management's HZNP Position: Q2 2015 in Review

Landscape Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2015, closing a stake of 22,200 shares — an estimated $577K sold.

Landscape Capital Management first reported a position in HZNP in Q4 2014 and held it in 2 quarters. The position peaked at $577K in Q1 2015. 213 funds tracked by Wall St. Rank hold HZNP as of Q2 2015.

Landscape Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2015 after selling out during the quarter.
Landscape Capital Management sold 22,200 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2015, an estimated $577K.
Landscape Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and held it in 2 quarters.
Landscape Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $577K in Q1 2015.
213 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2015.

Based on Landscape Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.